One Global Service Provider Ltd
Incorporated in 1992, One Global Service
Provider Ltd is in the business of healthcare services[1]
- Market Cap ₹ 1,064 Cr.
- Current Price ₹ 544
- High / Low ₹ 790 / 217
- Stock P/E 15.3
- Book Value ₹ 72.3
- Dividend Yield 0.00 %
- ROCE 87.0 %
- ROE 65.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 97.2% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 59.1%
Cons
- Stock is trading at 7.53 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 159 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 2 | 0 | 4 | 6 | 18 | 63 | 147 | 498 | |
| 0 | 0 | 0 | 0 | 2 | 0 | 1 | 5 | 16 | 53 | 122 | 405 | |
| Operating Profit | -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 2 | 10 | 25 | 93 |
| OPM % | 73% | 14% | 68% | 23% | 9% | 15% | 17% | 19% | ||||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Profit before tax | -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 1 | 10 | 25 | 93 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -3% | -1% | 25% | 26% | 25% |
| -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 1 | 7 | 18 | 70 | |
| EPS in Rs | -0.14 | -0.11 | -0.13 | 0.27 | 0.38 | -0.42 | 3.28 | 1.48 | 1.94 | 10.01 | 26.00 | 35.56 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 167% |
| 3 Years: | 202% |
| TTM: | 239% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 97% |
| 5 Years: | 97% |
| 3 Years: | 269% |
| TTM: | 281% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 57% |
| 5 Years: | 130% |
| 3 Years: | 150% |
| 1 Year: | 97% |
| Return on Equity | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | 56% |
| 3 Years: | 59% |
| Last Year: | 65% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 20 | 20 |
| Reserves | -5 | -5 | -5 | -5 | -4 | -5 | -2 | -1 | 0 | 7 | 52 | 122 |
| 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 2 | 1 | 0 | 1 | 2 | 5 | 17 | 34 | 114 | |
| Total Liabilities | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 106 | 255 |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | |
| CWIP | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 2 | 1 | 0 | 3 | 5 | 9 | 28 | 104 | 253 | |
| Total Assets | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 106 | 255 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0 | -0 | -0 | -0 | 0 | -0 | 1 | 1 | 0 | 1 | 14 | 3 | |
| 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -0 | -0 | -0 | -0 | |
| 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -1 | -0 | |
| Net Cash Flow | -0 | 0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 1 | 14 | 2 |
| Free Cash Flow | -0 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | 1 | 14 | 3 |
| CFO/OP | 90% | 162% | 111% | -32% | 141% | 6% | 45% | 38% | 8% | 12% | 67% | 10% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365 | 149 | 0 | 242 | 164 | 152 | 134 | 159 | ||||
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Days Payable | 98 | |||||||||||
| Cash Conversion Cycle | 365 | 149 | 0 | 242 | 164 | 152 | 134 | 60 | ||||
| Working Capital Days | 421 | 37 | 149 | 135 | 76 | 57 | 59 | 77 | ||||
| ROCE % | -4% | -3% | -3% | 6% | 9% | -11% | 60% | 18% | 20% | 85% | 56% | 87% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations (Operational Scale) INR Lakhs |
|
||||||||||
| Return on Capital Employed (ROCE) % |
|||||||||||
| Return on Equity (ROE) % |
|||||||||||
| Capital Work-in-Progress (Stagnant Capacity) INR Lakhs |
|||||||||||
| Number of Permanent Employees Count |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
3 Jun - Newspaper Publication of Audited financial results for quarter and year ended 31st March, 2026.
-
Financial Results For Quarter And Year Ended 31St March, 2026
3 Jun - Revised FY26 audited standalone results filed after correcting a quarter-heading typo.
-
Board Meeting Outcome for Revised Outcome
3 Jun - Company resubmitted audited FY2026 results after correcting a quarter-end typo.
-
Corporate Action-Board approves Dividend
30 May - Board approved FY26 audited results, recommended Rs.1 final dividend, and reopened trading window from 2 June 2026.
-
Financial Results For The Quarter And Year Ended 31St March, 2026
30 May - FY26 audited standalone results approved; Rs.1 final dividend recommended; trading window reopens 2 June 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
a) OGSPL provides services in Life Sciences and Healthcare Solutions across the globe.
b) Company has expertise in mass
screening, diagnostics and healthcare sciences used by hospitals, healthcare professionals and government bodies.
d) Company has started providing consultancy and development in software
and other IT solutions
e) It provides a single online platform
with healthcare products ranging from
medical devices to medical consumables.